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Staphylococcus epidermidis is a major nosocomial pathogen primarily infecting immunocompromised indi-
viduals or those with implanted biomaterials (e.g., catheters). Biomaterial-associated infections often involve
the formation of a biofilm on the surface of the medical device. In S. epidermidis, polysaccharide intercellular
adhesin (PIA) is an important mediator of biofilm formation and pathogenesis. Synthesis of PIA is regulated
by at least three DNA binding proteins (IcaR, SarA, and B) and several environmental and nutritional
conditions. Previously, we observed the environmental conditions that increased PIA synthesis decreased
tricarboxylic acid (TCA) cycle activity. In this study, S. epidermidis TCA cycle mutants were constructed, and
the function of central metabolism in PIA biosynthesis was examined. TCA cycle inactivation altered the
metabolic status of S. epidermidis, resulting in a massive derepression of PIA biosynthetic genes and a
redirection of carbon from growth into PIA biosynthesis. These data demonstrate that the bacterial metabolic
status is a critical regulatory determinant of PIA synthesis. In addition, these data lead us to propose that the
TCA cycle acts as a signal transduction pathway to translate external environmental cues into intracellular
metabolic signals that modulate the activity of transcriptional regulators.
Staphylococcus epidermidis is the most frequently isolated
nosocomial pathogen from the blood cultures of adult and
pediatric intensive care unit patients in the United States of
America (48). Frequently, S. epidermidis infections involve the
formation of a biofilm on the surfaces of biomaterials (e.g.,
catheters) (77). A biofilm is a complex aggregation of bacteria
usually encapsulated by an adhesive exopolysaccharide matrix.
The exopolysaccharide matrix provides structural stability to
the biofilm, enhanced adhesion to surfaces, and protection
from host defenses and antibiotics (2, 50, 79). In S. epidermidis,
the exopolysaccharide facilitating bacterial adherence in a bio-
film is polysaccharide intercellular adhesin (PIA). PIA is an
N-acetylglucosamine polymer (44) of at least 130 residues (42)
whose synthesis requires the enzymes encoded by genes in the
intercellular adhesin (ica) operon (icaADBC) (27). The syn-
thesis of PIA is required for the maturation of biofilms (27),
important for evasion of the host innate immune system (79,
80), and critical in biomaterial-associated infections (55, 57).
Bacteria live in environments subject to rapid changes in the
availability of the nutrients necessary to provide energy and bio-
synthetic intermediates for the synthesis of macromolecules. Con-
sequently, bacterial survival depends on the ability to regulate
expression of genes coding for enzymes required for growth in the
altered environment. In pathogenic bacteria, adaptation to an
altered environment often includes activating transcription of vir-
ulence genes; hence, synthesis of many virulence determinants is
regulated by environmental/nutritional signals (e.g., nitrogen,
iron, and calcium) (47). Because PIA is the most important vir-
ulence determinant of S. epidermidis (2, 7, 38, 56, 57, 84), it is not
surprising that PIA synthesis is regulated by environmental and
nutritional signals (13, 16, 18, 22, 53).
Regulation of the icaADBC operon is complex, involving at
least two DNA binding proteins (IcaR and SarA) and the alter-
native sigma factor B. IcaR binds immediately 5 to the icaA
transcriptional start site and represses transcription of the ica
operon (9, 29). SarA is an essential positive effector of icaADBC
transcription that binds to the icaA promoter region (26, 74). B
affects PIA synthesis indirectly by regulating the expression of
icaR (34, 35, 52). In addition, the luxS quorum-sensing system has
a minimal effect on PIA synthesis and biofilm formation; how-
ever, the mechanism remains to be determined (82).
In Staphylococcus aureus, B is activated during stress condi-
tions and growth phase transitions (3, 81). Because S. epidermidis
icaADBC transcription and PIA synthesis are induced by envi-
ronmental and nutritional stresses, stress-dependent activation of
B has been a focal point of research into the environmental
regulation of PIA synthesis and biofilm formation (10, 26, 35).
Importantly, B does not respond directly to environmental sig-
nals; therefore, a second area of research interest has focused on
identifying the regulatory network controlling B activation,
which is involved in responding to environmental signals. The
activation of B involves an anti-sigma factor (RsbW) and an
anti-anti-sigma factor (RsbV) and resembles the process in the
closely related organism Bacillus subtilis (35). In the absence of
environmental stimuli, B is bound in a complex with RsbW.
Stress-inducing stimuli are hypothesized to activate the RsbU
phosphatase to dephosphorylate (activate) the anti-anti-sigma
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factor RsbV, which then binds RsbW in a competitive manner to
increase the concentration of free B (34, 35). Based on several
published studies, it seems likely that the B posttranslational
regulatory network is responsible for responding to some envi-
ronmental stresses (i.e., osmotic stress) but is only minimally in-
volved in responding to nutritional signals (e.g., glucose), suggest-
ing that there are other means for S. epidermidis to “sense”
nutritional signals (18, 35, 52).
Previously, we observed the environmental and nutritional
signals that enhance PIA synthesis also repress tricarboxylic
acid (TCA) cycle activity, leading us to hypothesize that re-
pression of TCA cycle activity would increase PIA accumula-
tion (78). To test this hypothesis, we incubated S. epidermidis
strain 1457 with very low concentrations of fluorocitrate, which
minimally inhibited TCA cycle activity, and determined the
amount of cell-associated PIA. As the concentration of fluo-
rocitrate in the culture medium was increased, the amount of
PIA produced increased proportionally (78). Fluorocitrate is a
highly toxic compound when metabolized to 4-hydroxy-trans-
aconitate by the TCA cycle enzyme aconitase, severely limiting
the usable concentration range (40, 46). In the present study,
we overcame this limitation by genetically inactivating the ac-
onitase gene in S. epidermidis strain 1457. The aconitase mu-
tant and complemented strains permitted a detailed analysis of
the function of central metabolism in PIA synthesis.
MATERIALS AND METHODS
Bacterial strains, bacteriophage, plasmids, and growth conditions. Bacterial
strains, bacteriophage, and plasmids used in this study are listed in Table 1. S.
epidermidis strain 1457 (43) was used in these studies because it is a known PIA-
and biofilm-producing strain. Escherichia coli strains were grown in 2 YT broth
or on 2 YT agar (58). S. aureus and S. epidermidis strains were grown in tryptic
soy broth without dextrose (TSB; BD Biosciences) supplemented with 0.25%
glucose or on TSB containing 1.5% (wt/vol) agar. S. epidermidis cultures were
inoculated 1:200 from overnight cultures (normalized for growth) into TSB,
incubated at 37°C, and aerated at 225 rpm with a flask-to-medium ratio of 7:1.
Bacterial growth was assessed by measuring the optical density at 600 nm or by
determining the number of CFU ml1. Antibiotics were purchased from Fisher
Scientific or Sigma Chemical and were used at the following concentrations:
ampicillin (100 g/ml for E. coli), chloramphenicol (8 g/ml), erythromycin (8
g/ml), minocycline (2 g/ml), and trimethoprim (10 g/ml).
Staphylococcus epidermidis mutant construction. (i) Aconitase (acnA) mutant.
A 1.7-kb internal PCR product of the acnA gene of S. epidermidis strain 1457 was
amplified using primers 663 forward (contains a KasI restriction site) and 664
reverse (contains a PstI restriction site) (Table 2) and cloned into pGEM-T
(Promega). The 1.7-kb PCR product was excised from pGEM-T by digestion
with KasI and PstI and ligated into the KasI and PstI sites of pUC19 (83) to
generate the plasmid pNF103. The tetM cassette from plasmid pJF12 (from J.
Finan and G. Archer) was inserted into a unique EcoRI site of pNF103 at
nucleotide position 856 of the 2,702-bp acnA gene to generate the pNF117
plasmid. The temperature-sensitive plasmid pROJ6448 (51) was digested with
PstI and ligated into the unique PstI site of pNF117. The resulting temperature-
sensitive plasmid pNF118 was passaged through S. aureus strain RN4220 and
introduced into S. epidermidis strain 1457 by electroporation (59). Strain 1457
containing plasmid pNF118 was used to construct an acnA::tetM mutant as
described previously (19). The resulting mutant was backcrossed into wild-type
strain 1457 using transducing phage 71 (15). Inactivation of the acnA gene by
tetM cassette was verified by PCR, Southern blot analysis (68), and enzymatic
assays (64).
(ii) Citrate synthase (citZ) and isocitrate dehydrogenase (citC) double mutant.
The genes coding for citrate synthase and isocitrate dehydrogenase are present
in a two-gene operon and cotranscribed. To inactivate the citZC operon, a gene
splicing by overlap extension technique was used to replace a 2-kb internal DNA
region of citZC by the ermB gene. The ermB gene was amplified from pEC4 (5)
using primers citC-r-ermB2 and citZ-f-ermB (Table 2), containing sequences
homologous to the citC and citZ genes. Genomic DNA from S. epidermidis strain
TABLE 1. Bacterial strains, bacteriophage, and plasmids used in this study
Bacterial strain, bacteriophage,
or plasmid Relevant properties
a Source or reference
Bacterial strains
DH5 E. coli cloning host Invitrogen
RN4220 S. aureus restriction-deficient strain 8325-4 49
1457 S. epidermidis biofilm-forming strain 43
1457-acnA Strain 1457 acnA inactivated mutant; Minr This study
1457-citZC Strain 1457 citCZ deletion mutant; Ermr This study
1457-ica Strain 1457 icaADBC deletion mutant; Tmpr 26
1457-icaR Strain 1457 icaR inactivated mutant; Minr 26
1457-sigB Strain 1457 sigB inactivated mutant; Tmpr 26
1457-sarA Strain 1457 sarA inactivated mutant; Minr 26
Bacteriophage 71 S. epidermidis transducing phage 15
Plasmids
pCL15 Expression vector; derivative of pSI-1; Camr Chia Lee
pEC4 pBluescript II KS() with ermB inserted into ClaI site; Ampr Ermr 5
pJF12 Plasmid pCR2.1 containing tetM; Ampr Minr J. Finan and G. Archer
pGEM-T E. coli TA cloning vector; Ampr Promega
pMRS2 pCL15 with acnA gene under the control of the Pspac promoter; Cam
r This study
pMRS5 Derivative of pTS1-d with citZC::ermB fragment; Ampr Camr Ermr This study
pNF103 pUC19 with 1.7-kb internal fragment of acnA; Ampr This study
pNF117 pNF103 with tetM inserted into EcoRI site; Ampr Minr This study
pNF118 pRO6448::pNF117; Ampr Ermr Minr This study
pRO6448 pE194(ts) with AluI fragment (oriT) of pC221 cloned into the unique ClaI site; Ermr 51
pTS1 Shuttle vector; pE194orits; ColE1; Ampr Camr 24
pTS1-d Derivative of pTS1 with deletion of plasmid-encoded 3 region of ermC This study
pUC19 E. coli cloning vector; Ampr 83
a Ampr, ampicillin resistant; Camr, chloramphenicol resistant; Ermr, erythromycin resistant; Minr, minocycline resistant; Tmpr, trimethoprim resistant; ts, temper-
ature-sensitive origin of replication.
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1457 was used as a template for PCR amplification of the DNA flanking the
internal citZC region. Primers ansP-SacI and ermB-citZ-r (Table 2) were used
for amplification of a 1.9-kb region of the citZ upstream region. A 1.7-kb region
of the citC downstream region was amplified using phoP-BamHI and ermB-
citC-f2 primers (Table 2). The resulting 4.6-kb PCR product consisted of a 1-kb
ermB gene with DNA flanking the internal citZC regions. The 4.6-kb PCR
product contained SacI and BamHI sites that were used for ligation into pTS1-d
digested with SacI and BamHI to generate pMRS5. The temperature-sensitive
plasmid pTS1-d is a derivative of pTS1 (24) with deletion of the plasmid-encoded
3 region of the ermC gene. It was constructed by PCR amplification of pTS-1
DNA using primers pTS1dErm-f and pTS1dErm-r, and the resulting PCR prod-
uct was self-ligated as described previously (45). Plasmid pMRS5 was used to
construct a strain 1457 citZC double mutant (1457-citZC::ermB) (19). Allelic
replacement of the internal region of citZC genes by the ermB cassette was
verified by PCR and Southern blot analysis.
Construction of the complementation plasmid. Plasmid pCL15 (a kind gift of
Chia Lee), containing a Pspac promoter, was used for the construction of an acnA
complementation plasmid. The pMRS2 complementation plasmid was con-
structed by amplifying the 2.7-kb promoterless acnA gene from S. epidermidis
strain 1457 using SalI-SD-acnA-f and SacI-acnA-r primers, followed by ligation
of the PCR product into plasmid pCL15 digested with SalI and SacI. Plasmid
pMRS2 was isolated from S. aureus strain RN4220 and electroporated into S.
epidermidis strain 1457 (59). Plasmid pMRS2 was introduced into strain SE1457-
acnA using transducing phage 71 (49). Induction of expression from the Pspac
promoter was performed by supplementing bacterial cultures with isopropyl-	-
D-thiogalactopyranoside (IPTG) (1 mM).
Measurement of acetic acid and glucose concentrations in culture medium.
Aliquots of bacteria (2 ml) were centrifuged for 3 min at 14,000 rpm at 4°C, and
the supernatants were removed and stored at 20°C until use. Acetate and
glucose concentrations were determined with kits purchased from R-Biopharm
and used according to the manufacturer’s protocol.
Determination of NAD, NADH, and ATP concentrations. Intracellular
NAD and NADH concentrations were determined with an enzymatic cycling
assay kit (Biovision). Briefly, aliquots (5 to 20 ml) were harvested at 2, 3, 4, 5, and
6 h by centrifugation at 4°C for 10 min at 4,000 rpm. Bacterial pellets were
suspended in 1 ml of extraction buffer (Biovision) and lysed using lysing matrix
B tubes (Qbiogene) in a FastPrep instrument (Qbiogene). The lysate was cen-
trifuged at 4°C for 5 min at 14,000 rpm. NAD and NADH concentrations were
determined according to the manufacturer’s protocol and normalized to the cell
density. All assays were performed in duplicate for two independent experi-
ments.
Intracellular ATP concentrations were determined using the Enliten ATP
assay (Promega). Briefly, 2  107 bacteria were collected at 2, 3, 4, 5, and 6 h,
washed three times with 1 ml of phosphate-buffered saline, and suspended in 100
l of phosphate-buffered saline. Bacteria were lysed by the addition of 900 l of
dimethyl sulfoxide (23). ATP concentrations were determined according to the
manufacturer’s protocol and normalized to the cell density. All assays were
performed in duplicate for two independent experiments.
Determination of aconitase activity. Cell-free lysates of S. epidermidis were
prepared as follows: aliquots of bacteria (2 ml) were harvested by centrifugation
and suspended in 750 l of lysis buffer containing 90 mM Tris (pH 8.0) and 100
M fluorocitrate. The samples were lysed using lysing matrix B tubes (Qbiogene)
in a FastPrep instrument (Qbiogene). The lysate was centrifuged for 5 min at
14,000 rpm and 4°C. Aconitase activity was assayed in the resulting cell-free
lysate as previously described (63). One unit of aconitase activity is defined as the
amount of enzyme necessary to give a A240 min1 of 0.0033 (1). Protein
concentrations were determined by the method of Lowry (41).
PIA immunoblot assay. PIA accumulation was determined as described pre-
viously (78). Briefly, TSB medium containing 0.25% glucose was inoculated with
equal numbers of bacteria from overnight cultures. The cultures were grown at
37°C, with a flask-to-medium ratio of 7:1, and aerated at 225 rpm. Every 2 h,
equal numbers of bacteria (0.25 A600 unit) were harvested by centrifugation, and
the PIA was extracted in 0.5 M EDTA (pH 8.0) by boiling for 5 min. Aliquots of
PIA were applied to a polyvinylidene difluoride membrane (Immobilon-P; Mil-
lipore) and blocked with 5% skim milk overnight. The polyvinylidene difluoride
membrane was incubated for 2 h with PIA-specific antiserum (generously pro-
vided by Michael Otto), which was followed by a 2-h incubation with an anti-
rabbit immunoglobulin G peroxidase conjugate. The presence of PIA was de-
tected using SuperSignal West Pico chemiluminescent substrate (Pierce). The
integrated density values of bands on autoradiographs were determined with the
TotalLab software (Nonlinear Dynamics Ltd.)
Northern blot analysis. Northern blot analysis of transcripts was performed as
described previously (58), except that total RNA was isolated using the FastRNA
Pro Blue kit (Qbiogene) and purified using an RNeasy kit (Qiagen). Oligonu-
cleotide primers (Table 2) used in making DNA probes were designed using
the S. epidermidis RP62A genome sequence (GenBank accession number
CP000029). Probes for Northern blotting were generated by PCR amplification
of unique internal regions of glmM, glmS, glmU, icaD, icaR, pgi, sarA, and sigB
genes and labeled using the North2South random prime labeling kit (Pierce).
Electrophoresis, transfer of the RNA to the Nytran SPC nylon membrane
(Whatman), and hybridization were done using the NorthernMax kit (Ambion).
Detection was performed using the chemiluminescent nucleic acid detection
module (Pierce). When necessary, reprobing of blots was done according to the
manufacturer’s protocol.
NMR data collection, processing, and analysis. Nuclear magnetic resonance
(NMR) samples were prepared from three independent cultures (50 ml) of S.
epidermidis strains 1457 and 1457-acnA during the exponential growth phase (2
h) and postexponential growth phase (6 h) using [13C6]glucose (Cambridge
TABLE 2. Oligonucleotide primers used in this study
Primer Nucleotide sequence (533)
663 forward .............................GCGCGCGGCGCCGGGATATAAA
ATGGCTTCTA
664 reverse ..............................GCGCGCCTGCAGACCAGCAAGCG
CATAAGCTA
SERP1762(glmM)-f................CACCTGAATTGGCTTTTAAAC
TAGG
SERP1762(glmM)-r................TCAACACGATATTTGTCAGTC
ACTC
SERP1760(glmS)-f .................GTGTGGAATTGTTGGTTATAT
TGGC
SERP1760(glmS)-r .................GCTTCACGTGATAATGTTGAACC
glmU-f......................................CGATTATTCTGGCAGCAGGTAAG
glmU-r......................................CGATTGATACGTTGTTGCAAAGC
icaProbeforward......................GACAGTCGCTACGAAAAG
icaProbereverse.......................CCGAATAATTTGTAAATTTCC
icaR-r .......................................GGAGGCTCTAAAATACCAAG
TCTC
icaR-f .......................................GGTACGATGGTACTACACTT
GATG
pgi-f ..........................................GCATGAACTAGATCAGCAAAAGG
ATATTG
pgi-r ..........................................GCTGTAAGAACAGAATAACGAC
CTCC
sarA-f .......................................GGCTATTTCAAAAATCAATGACT
GCTTTG
sarA-r .......................................GCTTCTGTGATACGGTTGTTT
ACTC
sigB-f ........................................CGAAAGAGTCGAAATCAGCT
AGTG
sigB-r........................................GTGAAACATGCATTTGACTAA
GACC
SalI-SD-acnA-f........................CTAAGTCGACAATATCAAGGGGG
ATATAAAATGGCTTC
SacI-acnA-r .............................CAAGAGCTCATGACTG CTTGTAC
TCAATAGTGAG
pCL15-f....................................GTTCTACATCCAGAACAACCT
CTGC
pCL15-r....................................GAAATGATGACCTCGTTTCC
ACCG
citC-r-ermB2 ...........................GACGTTCTGTACCTTCTTTAGGCG
ACTCATAGAATTATTTCCTCCC
citZ-f-ermB..............................CACTTTGAGGAGTATGTGACGAA
GGAGGGATTCGTCATGTTG
phoP-BamHI...........................GGaGGATCCACGTACAGTCTTTAT
CAATTTAGGTTGC
ermB-citC-f2............................GGAAATAATTCTATGAGTCGCCT
AAAGAAGGTACAGAACGTCTA
GTAAGAG
ansP-SacI .................................GCAGAGCTCACTAAGTGTCGATG
TAAATTTTATCGTGC
ermB-citZ-r .............................GACGAATCCCTCCTTCGTCACATA
CTCCTCAAAGTGCTTGTATAC
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Isotope Laboratories) in place of glucose in the growth medium. Bacteria were
rapidly harvested, lysed using lysing matrix B tubes (Qbiogene) in a FastPrep
instrument (Qbiogene), and centrifuged to remove the cell debris. Samples were
lyophilized, suspended in a 99.8% D2O (Isotec) 50 mM phosphate buffer, and an
aliquot (500 l) was transferred to an NMR tube for analysis.
The NMR spectra were collected on a Bruker 500-MHz Avance spectrometer
equipped with a triple-resonance, z-axis gradient cryoprobe. A BACS-120 sample
changer with Bruker Icon software was used to automate the NMR data collec-
tion. Two-dimensional (2D) 1H-13C-heteronuclear single quantum coherence
(1H-13C-HSQC) spectra were collected with a Bruker pulse sequence (HSQCE
TGP), solvent presaturation, and relaxation delay of 0.5 s. A total of 1,024 data
points with a sweep width of 4734.85 Hz and 64 data points with a sweep width
of 13834.26 Hz were collected in the 1H and 13C dimensions, respectively. A total
of eight dummy scans and 128 scans were used to obtain each of the 2D 1H-13C
HSQC NMR spectra. Spectra were processed using the NMRPipe software
package (17) and zero-filled with 2,048 and 1,024 points in the 1H and 13C
dimensions, respectively. Additionally, the spectra were Fourier transformed,
manually phased, and baseline corrected.
Spectra were analyzed using Primitive Interactive Peak Picker (PIPP) (20) to
determine chemical shifts and peak intensities. The chemical shifts were divided
into three groups (Tables 3 and 4) based on the intensities of similar peaks
between the wild-type and acnA mutant strains during the exponential and
postexponential phases of growth. Peak intensities were normalized for each
spectrum by dividing by the average peak intensity. The triplicate data sets were
then used to calculate average peak intensities for each peak observed in the 2D
1H-13C HSQC spectra for the wild-type and acnA mutant. Similarly, a percent
error was calculated for each peak by dividing the standard deviation by the
average peak intensity. The average peak intensities were then used to calculate
a percent difference between the wild-type and acnA mutant. Peaks with calcu-
lated percent differences greater than five times the average percent error were
considered to have increased concentrations in the wild-type or acnA mutant
strains. Peaks with less than a fivefold deviation were considered similar. The
peaks assigned to the same metabolite were required to have the same relative
change in intensity in order to be classified as a metabolite with an increase in
concentration.
NMR peaks were assigned to specific metabolites using the Madison Metabo-
lomics Consortium Database (14) using a tolerance of 0.05 ppm and 0.50 ppm for
1H and 13C dimensions, respectively. The presence of metabolites and metabolic
pathways were verified with the KEGG (31) and Metacyc (32) databases. NMR
reference data available from the Madison Metabolomics Consortium Database
is incomplete, so it is currently not feasible to assign every NMR resonance
observed in the 2D 1H-13C HSQC NMR spectra to a S. epidermidis metabolite.
It is also important to note that the combination of 2D 1H-13C HSQC NMR
spectra with isotopically enriched (e.g., [13C6]glucose) cellular extracts enables
the measurement of accurate metabolite concentration changes relative to one-
dimensional 1H NMR metabolomic methods alone. Generally, only compounds
that are metabolic products of [13C6]glucose were detected.
Statistical analysis. The statistical significance of changes between wild-type
and mutant strains (e.g., ATP concentrations) was assessed with the Student’s t
test. To determine whether a correlation existed between two physiological
parameters, a correlation coefficient (
) was calculated.
RESULTS
Construction and characterization of an S. epidermidis
strain 1457 aconitase mutant. Partial biochemical inhibition of
TCA cycle activity in S. epidermidis increased the accumulation
of PIA (78). Because fluorocitrate is very toxic, we were unable
to completely block TCA cycle activity without killing the bac-
teria. To overcome this obstacle, we inactivated the TCA cycle
in S. epidermidis strain 1457 by insertion of a tetM cassette into
the gene encoding aconitase (acnA; also known as citB) and
then assessed the effect on PIA synthesis. In S. epidermidis,
aconitase is present as a sole copy on the chromosome; hence,
inactivation of aconitase results in a nonfunctional TCA cycle.
Inactivation of the aconitase gene in S. epidermidis strain 1457
by allelic replacement was genotypically verified by PCR and
Southern blot analysis (data not shown) and phenotypically by
aconitase enzymatic activity assays (Fig. 1A). In addition, over-
all TCA cycle function was assessed by measuring the accumu-
lation and depletion of acetic acid from the culture medium of
the wild-type, mutant, and complemented strains (Fig. 1D).
(Acetic acid catabolism in staphylococci requires a fully func-
tional TCA cycle [64, 65].) As expected, aconitase inactivation
inhibited the postexponential oxidative catabolism of acetic
acid (Fig. 1D). Of importance, when the concentration of ace-
tic acid in the culture medium was plotted as a function of
growth, the exponential growth phase rates of acetic acid ac-
cumulation in strains 1457 and 1457-acnA were equivalent
(data not shown), suggesting that carbon utilization in both
strains was proceeding through glycolysis and the acetate ki-
nase/phosphotransacetylase pathway at a similar rate. The
equivalent rate of acetic acid accumulation in strains 1457 and
1457-acnA was also supported by NMR metabolomic analysis
(Table 3). If carbon flow through glycolysis were equivalent,
TABLE 3. Summary of metabolic differences identified in
S. epidermidis strains by NMR after 2 h of growth
Increased
intracellular
concn in the
wild-type
strain 1457a
Increased intracellular
concn in strain
1457-acnAa
Similar intracellular
concns in wild-type
and 1457-acnA strains
Lactic acid Valine Acetate
Succinate Leucine Glucose
Glutamate Lysine Glucosamine
Glutamine Citrate Ethanol
Asparagine Serine Glucose-6-phosphate
Aspartate Arginine Inosine
Fructose-6-phosphate Adenosine
Glucono-1,5-lactone Xanthosine
Acetaldehyde N-Acetylglutamate
Isoleucine NAD
Ornithine Uridine
UDP-N-acetylglucosamine Alanine
a The intracellular concentration was considered to be increased when the
percent difference in the NMR peak intensities was fivefold greater than the
percent error observed in the peak intensities between the triplicate NMR
spectra.
TABLE 4. Summary of metabolic differences identified in
S. epidermidis strains by NMR after 6 h of growth
Increased
intracellular concn
in the wild-type
strain 1457a
Increased intracellular
concn in strain
1457-acnAa
Similar intracellular
concns in wild-type
and 1457-acnA strains
Glutamine Ethanol Glucosamine-6-
phosphate
Glutamate Alanine Glucose
Ornithine Lactate Ribose
Succinate Acetate Glucose-6-
phosphate
Asparagine Acetaldehyde NAD
Aspartate Citrate UDP-glucuronate
-Aminobutanoate UDP-N-acetylglucosamine Ribose-5-phosphate
Isocitrate Uridine Inosine
Fructose-6- Adenosine
phosphate Xanthosine
a The intracellular concentration was considered to be increased when the
percent difference in the NMR peak intensities was fivefold greater than the
percent error observed in the peak intensities between the triplicate NMR
spectra.
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then it is reasonable to predict that the growth rate of the
wild-type and aconitase mutant strains would also be equiva-
lent. Surprisingly, the growth rate of strain 1457-acnA was
lower than the growth rate of the isogenic wild-type strain, and
this was reflected in the temporal depletion of glucose (Fig.
1C). This result was surprising because TCA cycle activity is
repressed during the exponential growth phase when nutrients
are abundant; thus, inactivating a repressed metabolic pathway
should have minimal consequences. Restoration of the growth
rate and the ability to catabolize acetate was accomplished by
complementation of the strain 1457-acnA mutation with a plas-
mid (pMRS2) containing the acnA gene under the control of a
Pspac promoter (Fig. 1A to D). As a whole, these date demon-
strate that acnA was inactivated, and this resulted in a meta-
bolic block in the TCA cycle.
TCA cycle inactivation redirects carbon from growth into
UDP-N-acetylglucosamine biosynthesis. When grown in the
presence of a rapidly catabolizable carbon source, gram-posi-
tive bacteria repress the TCA cycle; hence, there is an accu-
mulation of acidic secondary metabolites (e.g., acetate) in the
culture medium. Derepression of the TCA cycle occurs upon
depletion of the readily catabolizable carbon source(s) and
coincides with the depletion of acetate from the culture me-
dium. The processing of glucose through glycolysis and the
resulting accumulation of acetate during substrate-level phos-
phorylation were equivalent in S. epidermidis strains 1457 and
1457-acnA; hence, the lower growth rate of strain 1457-acnA
relative to the wild-type strain was likely due to a redirection of
carbon and energy from growth into other cellular processes or
metabolic pathways. If carbon and/or energy were diverted
from growth to another metabolic pathway or process, then the
number of bacteria produced per unit of glucose consumed
should be lower in the aconitase mutant strain than in the
wild-type strain. Plotting the glucose concentrations in the
culture medium as a function of optical density at 600 nm for
three independent experiments (Fig. 2) confirmed that fewer
bacteria are produced per unit of glucose consumed by strain
1457-acnA than by strain 1457. These data strongly suggest that
carbon and/or energy were diverted from growth into other
cellular processes. To determine the metabolic pathways into
which carbon might be redirected, we utilized NMR metabo-
lomics to assess the metabolic status of strains 1457 and 1457-
acnA in the exponential growth phase (2 h) and the postexpo-
nential growth phase (6 h) (see Fig. S1 and S2 in the
supplemental material) (Tables 3 and 4). As expected, TCA
cycle inactivation decreased the intracellular concentration of
amino acids derived from TCA cycle intermediates (Asn, Asp,
Gln, and Glu) and increased accumulation of the PIA biosyn-
thetic precursor UDP-N-acetylglucosamine. Interestingly,
TCA cycle inactivation resulted in an exponential-growth-
phase accumulation of branched-chain amino acids relative to
the wild-type strain (see Fig. S1 in the supplemental material)
FIG. 1. Growth characteristics of the S. epidermidis strain 1457 aconitase mutant. (A) Aconitase activity of S. epidermidis strains 1457,
1457-acnA, and 1457-acnA containing pMRS2 (1457-acnA  pMRS2) was determined 6 h postinoculation. (B) Growth curves of wild-type strain
1457, aconitase mutant strain 1457-acnA, and strain 1457-acnA containing the complementing plasmid pMRS2 grown in TSB containing 0.25%
glucose. At the indicated times, aliquots were removed, and the optical density at 600 nm (O.D.600) was measured, and the pH of the culture
medium was determined. (C) Temporal depletion of glucose from the culture medium of strains 1457, 1457-acnA, and 1457-acnA containing
pMRS2. (D) Temporal accumulation and depletion of acetic acid in the culture medium of strains 1457, 1457-acnA, and 1457-acnA containing
pMRS2. The results are representative of at least two independent experiments.
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(Table 3). In addition to increasing the carbon flow into
branched-chain amino acid biosynthesis, the presence of a high
concentration of glucono-1,5-lactone in strain 1457-acnA sug-
gests that inactivation of the TCA cycle increased carbon flow
into the pentose phosphate pathway.
NMR metabolomics indicated that TCA cycle inactivation
redirected carbon into UDP-N-acetylglucosamine biosynthesis
(Tables 3 and 4). If carbon were being redirected into UDP-
N-acetylglucosamine biosynthesis, then it is likely that tran-
scription of genes coding for the UDP-N-acetylglucosamine
biosynthetic enzymes would be increased. To determine
whether TCA cycle inactivation altered the transcription of
UDP-N-acetylglucosamine biosynthetic genes, we probed total
RNA for pgi (glucose-6-phosphate isomerase), glmS (glucos-
amine-6-phosphate synthase), glmM (phosphoglucosamine
mutase), and glmU (UDP-N-acetylglucosamine pyrophosphor-
ylase) (Fig. 3). Consistent with metabolomic data indicating an
increased intracellular concentration of fructose-6-phosphate,
transcription of pgi was slightly increased in S. epidermidis
strain 1457-acnA relative to strain 1457 during the exponential
growth phase. (Glucose-6-phosphate isomerase catalyzes the
second step in glycolysis, specifically, the reversible isomeriza-
tion of glucose-6-phosphate into fructose-6-phosphate.) Fruc-
tose-6-phosphate is the biosynthetic precursor of UDP-N-
acetylglucosamine, whose biosynthesis is encoded within the
genes glmS, glmM, and glmU. The exponential-growth-phase
mRNA levels of glmS, glmM, and glmU were increased in strain
1457-acnA relative to strain 1457. Taken together, these data
demonstrate that TCA cycle inactivation results in transcrip-
tional changes that redirect carbon into N-acetylglucosamine
biosynthesis.
In addition to providing biosynthetic intermediates, the
TCA cycle generates ATP and reducing potential; therefore, a
metabolic block in the TCA cycle will alter the energy status of
the bacterium. As an indicator of the energy status, the intra-
cellular concentrations of NAD, NADH, and ATP were de-
termined for S. epidermidis strains 1457 and 1457-acnA. The
intracellular concentration of ATP was lower in the aconitase
mutant strain relative to the wild-type strain during both the
exponential and postexponential growth phases (Fig. 4C). This
decreased ATP concentration was likely due to decreased ox-
idative phosphorylation, as the intracellular concentrations of
NAD and NADH were significantly (P  0.01) lower in the
aconitase mutant strain than in the wild-type strain (Fig. 4A
and B).
TCA cycle inactivation increases PIA accumulation. To de-
termine whether TCA cycle inactivation resulted in increased
synthesis of PIA, we assessed the relative amounts of cell-
associated PIA in the acnA mutant, the complemented acnA
mutant, and the wild-type strains using a PIA immunoblot
assay (Fig. 5A and B). In addition, to facilitate comparison of
the effect of TCA cycle inactivation on PIA accumulation with
the inactivation of well-established regulators (i.e., IcaR, B,
and SarA), we determined the relative amounts of cell-associ-
ated PIA for isogenic strains that had icaR, sarA, or sigB ge-
netically inactivated. In agreement with previous studies (9, 10,
26, 35, 74), we observed that mutations in the genes of positive
regulators sigB and sarA decreased PIA accumulation relative
to the wild-type strain, while inactivation of icaR increased PIA
accumulation (Fig. 5A and B). Surprisingly, aconitase inacti-
vation had a much greater effect on PIA synthesis than did
inactivation of the well-studied repressor IcaR (Fig. 5A and B).
Complementation of the acnA mutation restores PIA accumu-
lation to that seen in the parental strain (Fig. 5A and B).
In B. subtilis, aconitase inactivation results in the accu-
mulation of citric acid, which is partially responsible for
blocking sporulation and causing a slight decrease in the
growth rate (12). NMR metabolomics revealed an accumu-
lation of citric acid in the aconitase mutant strain relative to
the wild-type strain (see Fig. S1 and S2 in the supplemental
material) (Tables 3 and 4), raising the possibility that the
increased accumulation of PIA and the decreased growth
rate of S. epidermidis strain 1457-acnA relative to strain 1457
might be due to citric acid-induced stress. To address these
FIG. 2. TCA cycle inactivation redirects glucose carbons away from
growth. The concentrations of glucose in the culture medium of S.
epidermidis strains 1457 and 1457-acnA were plotted as a function of
growth. The data are from three independent experiments, and the
line is a linear regression of these data generated using SigmaPlot 10.0.
O.D.600, optical density at 600 nm.
FIG. 3. Northern blot analysis of UDP-N-acetylglucosamine bio-
synthetic genes in S. epidermidis strains 1457 and 1457-acnA. At the
indicated times during the growth cycle, total RNA was isolated from
strains 1457 and 1457-acnA, and Northern blot analysis was performed
using the indicated probes. To ensure that equivalent quantities of
RNA were loaded, 23S and 16S rRNA were visualized by ethidium
bromide staining and used as loading controls (bottom panel). The
results are representative of at least two independent experiments.
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possibilities, we inactivated both citrate synthase (citZ) and
isocitrate dehydrogenase (citC) in S. epidermidis strain 1457
and assessed growth and assayed for PIA accumulation
(data not shown). Similar to the aconitase mutant strain, the
citCZ double mutant dramatically increased PIA accumula-
tion. Additionally, the citCZ double mutant had a decreased
growth rate relative to the wild-type strain, but the growth
rate was increased relative to strain 1457-acnA (data not
shown), suggesting that citric acid accumulation was par-
tially responsible for the slower growth of the aconitase
mutant. Taken together, these data demonstrate that TCA
cycle activity represses S. epidermidis PIA accumulation and
that this effect is independent of citric acid.
TCA cycle activity represses icaADBC transcription. TCA
cycle inactivation alters the metabolic status of S. epidermi-
dis (Fig. 1A to D and 3 and Tables 3 and 4), raising the
possibility that an icaADBC transcriptional regulator could
respond to the altered metabolic environment to increase
icaADBC transcription. To determine whether the increased
accumulation of PIA by the acnA mutant strain was due to
altered icaADBC transcription, we examined icaADBC
mRNA levels in S. epidermidis strains 1457 and 1457-acnA.
In addition, icaADBC mRNA levels were determined for
strain 1457 with mutations in sigB, sarA, or icaR. Consistent
with the PIA immunoblot data (Fig. 5A and B), aconitase
inactivation resulted in a very large increase in icaADBC
transcription, or mRNA stability, relative to the isogenic
wild-type strain (Fig. 6A and B), demonstrating that TCA
cycle activity represses icaADBC transcription. In agree-
ment with previous results, we observed that sigB and sarA
inactivation repressed icaADBC transcription and that icaR
inactivation derepressed icaADBC transcription (9, 11, 26).
Interestingly, the extent of derepression in the 1457-acnA
mutant strain was dramatically higher than seen in an iso-
genic icaR mutant (Fig. 6A and B), suggesting TCA cycle
activity has a greater role in regulating icaADBC transcrip-
tion than does IcaR. These data demonstrate that, like reg-
FIG. 4. Aconitase inactivation alters the redox and energy status of
S. epidermidis. (A) At the indicated times during the growth cycle,
intracellular concentrations of NAD and NADH were determined in
S. epidermidis strain 1457. (B) Similarly, the concentrations of reduced
and oxidized NAD were determined for strain 1457-acnA. (C) ATP
concentrations were determined for strains 1457 and 1457-acnA. The
results are presented as the means plus standard errors of the means
(error bars) of duplicate determinations for at least two independent
experiments.
FIG. 5. TCA cycle inactivation increases PIA accumulation.
(A) Relative amounts of cell-associated PIA were determined using a
PIA immunoblot assay for S. epidermidis strains 1457, 1457-acnA,
1457-sigB, 1457-sarA, 1457-icaR, and 1457-acnA containing pMRS2
(1457-acnA pMRS2). To determine the relative amounts of PIA, we
defined the amount of PIA produced by strain 1457 at 2 h in one
experiment as 100% and expressed all other amounts as relative to the
amount at this 2-h point. The results are presented as the means plus
standard errors of the means (error bars) for three independent ex-
periments. (B) Representative immunoblot used for determining spot
volumes. Strain 1457-ica, which does not synthesize PIA, was used to
determine the background density.
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ulation of the lac operon, icaADBC transcription is regu-
lated by a catabolic process, specifically, the TCA cycle.
TCA cycle inactivation alters transcription of icaR, sarA,
and sigB. As stated, transcription of icaADBC requires at
least two positive effectors, SarA and B, and one negative
regulator, IcaR. The dramatic increase in icaADBC mRNA
levels in the aconitase mutant strain relative to the wild-type
strain could be due to an increased number of positive
effectors or a decreased number of negative effectors. To
determine whether aconitase inactivation altered transcrip-
tion of the known regulators of icaADBC transcription, we
probed total RNA isolated throughout the growth cycle for
changes in the transcription of sigB, sarA, and icaR (Fig. 7).
Surprisingly, aconitase inactivation increased transcription
or mRNA stability of both positive regulators sigB and sarA
and the negative regulator icaR. These data suggest that
TCA cycle inactivation can alter the mRNA levels of the
known regulators of PIA synthesis; however, they fail to
establish that these regulators are involved in TCA cycle-
mediated regulation of PIA synthesis. To determine
whether IcaR, SarA, or B is regulating PIA synthesis in
response to TCA cycle-associated metabolic changes, icaR,
sarA, and sigB regulatory mutants of strain 1457 were incu-
bated with 400 M of the aconitase inhibitor fluorocitric
acid, and PIA accumulation was assessed relative to the
parental strain 1457 (Fig. 8.) The addition of fluorocitric
acid to the culture medium of S. epidermidis strains 1457-
sigB and 1457-icaR significantly (P  0.01) increased the
accumulation of PIA relative to the untreated control cul-
tures. In strain 1457-sarA, the accumulation of PIA was
similar irrespective of the presence of fluorocitric acid in the
culture medium (P  0.05). Overall, these data suggest that
TCA cycle-mediated derepression of ica transcription and
PIA synthesis occur independently of IcaR and B. Further-
more, these data confirm that PIA synthesis requires SarA
(10, 74) and at least one additional TCA cycle-responsive
negative regulator.
FIG. 6. TCA cycle inactivation derepresses icaADBC transcription.
Total RNA was isolated from S. epidermidis strains 1457 and 1457-
acnA, 1457-sarA, 1457-icaR, and 1457-sigB, and Northern blot analysis
was performed using an icaD-specific probe. To make certain equiva-
lent quantities of RNA were loaded, 23S and 16S rRNA were visual-
ized by ethidium bromide staining and used as loading controls (bot-
tom blots). To permit direct comparison of autoradiographs, total
RNA from strains 1457-acnA and 1457 isolated at 6 h and 4 h posti-
noculation, respectively, were used to normalize the exposure times.
(To minimize variation, the same preparations of RNA were used as
exposure controls in all experiments.) The results are representative of
at least two independent experiments.
FIG. 7. Aconitase inactivation increases transcription of icaR, sarA,
and sigB. Northern blot analysis with icaR, sarA, and sigB with DNA
probes generated using primers shown in Table 2. To ensure that
equivalent quantities of RNA were loaded, 23S and 16S rRNA were
visualized by ethidium bromide staining and used as loading controls
(bottom blot). The results are representative of at least two indepen-
dent experiments.
FIG. 8. Partial biochemical inhibition of aconitase increases PIA
synthesis in sigB and icaR mutants. Bacterial cultures were incubated
with 400 M fluorocitric acid and grown for 2 h, and the relative
amounts of cell-associated PIA were determined by a PIA immunoblot
assay. The data are presented as the means plus standard errors of the
means (error bars) from three independent experiments. Values that
were significantly different (P  0.05) from the value for the isogenic
untreated control (0 M fluorocitrate) are indicated by an asterisk.
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DISCUSSION
Metabolic effect of TCA cycle activity on PIA biosynthesis.
Glycolysis is the catabolic pathway that converts glucose into
pyruvate, with the catabolic fate of pyruvate being determined
by the availability of oxygen. Interestingly, the rate of glucose
utilization by the wild-type S. epidermidis strain 1457 appears
greater than the rate by strain 1457-acnA (Fig. 1C); however,
these data fail to account for the number of bacteria in the
medium. When this is taken into account, glucose utilization
was greater in strain 1457-acnA than in strain 1457 (Fig. 2),
suggesting that carbon flow through glycolysis might be greater
in a TCA cycle mutant. If the amount of carbon flowing
through glycolysis were greater in a TCA cycle mutant than in
the parental strain, then the amount of acetate in the culture
medium at the time when glucose was depleted should be
greater in the mutant. Glucose was depleted in the wild-type
and complemented strains after 5 h of growth; however, in
strain 1457-acnA, glucose was depleted after 7 h of growth
(Fig. 1C). Upon depletion of glucose, the concentrations of
acetate in the culture medium were similar (14 to 16 mM) for
all strains (Fig. 1D), suggesting that carbon flow through gly-
colysis was similar in the aconitase mutant and the wild-type
strain. Additionally, because the concentrations of acetate
were below 24 mM (if all glucose is processed through the
glycolytic pathway, then a 2:1 stoichiometry of acetate to glu-
cose should be maintained), the data confirm that carbon are
flowing into other pathways. Consistent with these data, NMR
metabolomics indicated that the exponential-growth-phase
concentrations of acetic acid in strains 1457 and 1457-acnA
were similar (Table 3). In addition to glycolysis, another major
pathway staphylococci use for glucose catabolism is the pen-
tose phosphate pathway (8, 70). The presence of glucono-1,5-
lactone in the NMR metabolomic data (Table 3) suggests that
carbon flow through the pentose phosphate pathway is in-
creased in the TCA cycle mutant strain relative to the wild-type
strain. One function of the pentose phosphate pathway is to
provide the five-carbon intermediate for purine biosynthesis;
hence, the increased carbon flow through the pentose phos-
phate pathway is likely linked to the decreased intracellular
concentration of ATP in strain 1457-acnA relative to strain
1457 (Fig. 3). (De novo biosynthesis of ATP requires 5-phos-
phoribosyl-1-pyrophosphate. An important function of the
pentose phosphate pathway is to provide biosynthetic interme-
diates for purine biosynthesis, namely, ribose-5-phosphate that
is converted into 5-phosphoribosyl-1-pyrophosphate.)
NMR metabolomic data revealed an increased intracellular
concentration of fructose-6-phosphate in the TCA cycle mu-
tant relative to the wild-type strain (Table 3). Fructose-6-phos-
phate can undergo a transamination reaction to generate
glucosamine-6-phosphate, a reaction catalyzed by glucos-
amine-6-phosphate synthase (glmS; EC 2.6.1.16). Phosphoglu-
cosamine mutase (glmM; EC 5.4.2.10) catalyzes the reversible
isomerization glucosamine-6-phosphate to glucosamine-1-
phosphate. Glucosamine-1-phophaste is the substrate for the
bifunctional enzyme UDP-N-acetylglucosamine pyrophosphor-
ylase (glmU; EC 2.7.7.23 and EC 2.3.1.157) that catalyzes the
acetylation and UTP-dependent activation of glucosamine-
1-phosphate to generate UDP-N-acetylglucosamine. NMR
metabolomics confirmed that S. epidermidis strain 1457-acnA
has a greater intracellular concentration of UDP-N-acetylglu-
cosamine than strain 1457 does. In addition, transcription of
glmS, glmM, and glmU is increased more during the exponen-
tial growth phase in the TCA cycle mutant than in the wild-
type strain (Fig. 3). In total, these data demonstrate that TCA
cycle inactivation increased the availability of the PIA mono-
mer, UDP-activated N-acetylglucosamine and that this was
partially due to transcriptional derepression of N-acetylglu-
cosamine biosynthetic genes.
In addition to PIA synthesis, UDP-N-acetylglucosamine is
critical for biosynthesis of the cell wall components teichoic
acid and peptidoglycan. Inactivation of aconitase in S. epider-
midis decreased the growth rate (Fig. 1B) and the number of
bacteria produced per unit of glucose (Fig. 2), suggesting that
UDP-N-acetylglucosamine was redirected from cell wall bio-
synthesis to PIA synthesis (Fig. 5A). Thus, the decreased
growth rate of the aconitase mutant strain was likely due to a
combination of increased competition for substrate (i.e., UDP-
N-acetylglucosamine) by PIA biosynthetic enzymes and an ac-
cumulation of citric acid.
Regulatory effect of TCA cycle activity on PIA biosynthesis.
Two common mechanisms by which bacteria control carbon
flow are feedback inhibition of enzyme activity and regulation
of enzyme synthesis. Undoubtedly, some of the metabolic
changes arising from TCA cycle inactivation are the result of
feedback inhibition of enzyme activity; however, by definition,
the derepression of icaADBC transcription (Fig. 6A and B)
must be at the regulatory level. Although the prospect that
TCA cycle enzymes directly regulate icaADBC transcription is
a possibility, it is more likely that regulation is being mediated
by regulatory proteins responding to changes in the metabolic
status of the bacteria. Metabolic regulation was one of the first
bacterial regulatory modalities identified, resulting in thou-
sands of studies addressing all aspects of regulation. This long
history of research into metabolic regulation has identified a
large number of regulatory proteins capable of responding to
changes in the intracellular concentrations of molecules asso-
ciated with TCA cycle activity, such as NADH (e.g., Rex [4],
NmrA [39], and CcpA [21]), citric acid (CcpC [30, 33]), gluta-
mate (GadX and GadW [75]), branched-chain amino acids
(CodY [61]), and ATP (KinA [69]). These observations lead us
to hypothesize that a regulatory protein or proteins respond to
TCA cycle-associated metabolites and regulate icaADBC tran-
scription and PIA synthesis.
TCA cycle inactivation increased the transcription or
mRNA stability of the known regulators of icaADBC transcrip-
tion, specifically, sigB, sarA, and icaR (Fig. 7). These data raise
the possibility that TCA cycle-induced alterations in the met-
abolic status of the bacterium might be “sensed” by B, SarA,
or IcaR. Incubation of S. epidermidis strain 1457-sigB with a
low concentration of the TCA cycle inhibitor fluorocitric acid
restored PIA synthesis to wild-type levels (Fig. 8). This fluo-
rocitrate-induced derepression of PIA synthesis in the sigB
mutant strain is similar to that observed in an S. epidermidis
rsbU mutant strain (RsbU is an activator of B) treated with a
PIA synthesis-stimulating concentration of ethanol (34). In
that study, the authors found that ethanol could restore cell-
associated PIA accumulation in an rsbU mutant strain to a
level equivalent to that of the nonstimulated wild-type strain.
Because ethanol is an inhibitor of TCA cycle activity (6, 37), we
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hypothesize that the PIA synthesis-stimulating properties of
ethanol may be due to its TCA cycle inhibitory properties.
Inactivation of sarA in S. epidermidis dramatically decreases
icaADBC transcription (74) and PIA accumulation (26, 74)
and results in a biofilm-negative phenotype (10). Because SarA
is thought to be essential for PIA synthesis (74), the more likely
outcome of incubating S. epidermidis strain 1457-sarA with
fluorocitric acid would be equivalent PIA accumulation be-
tween the wild-type and sarA mutant strains. As expected, the
amount of PIA produced by strain 1457-sarA was similar irre-
spective of the presence of fluorocitric acid (Fig. 8). These data
are consistent with SarA being essential for PIA synthesis
and/or being required for responding to TCA cycle-associated
signals.
TCA cycle inactivation increased transcription or mRNA
stability of icaR relative to the wild-type strain (Fig. 7). IcaR is
a transcriptional repressor of icaADBC that was originally hy-
pothesized to be involved in environmental regulation of PIA
synthesis (9). For these reasons, IcaR appeared to be a possible
candidate for responding to TCA cycle-induced metabolic
changes. If IcaR were responding to TCA cycle-associated
metabolic changes, then in an icaR mutant background, the
synthesis of PIA should be unaffected by the presence of fluo-
rocitric acid. Growth of strain 1457-icaR in the presence of a
low concentration of fluorocitric acid significantly increased
the accumulation of PIA (Fig. 8), demonstrating that a second
repressor is involved in regulating PIA synthesis. It is likely
that this second repressor is responding to TCA cycle-associ-
ated metabolic signals.
NMR metabolomics (Table 3) indicated that the intracellu-
lar concentrations of branched-chain amino acids were greater
in the aconitase mutant strain than in the wild-type strain. In
gram-positive bacteria, the intracellular concentrations of
branched-chain amino acids control the expression of numer-
ous genes, a mechanism requiring the CodY regulatory protein
(25, 61, 66, 72). The affinity of CodY for its operator site is
enhanced in response to high intracellular concentrations of
GTP and branched-chain amino acids (54, 61). The more likely
explanations for our data are that CodY is an activator of
icaADBC transcription, CodY-mediated repression is not func-
tioning in S. epidermidis during the exponential growth phase,
or a positive effector, potentially SarA, can overcome CodY-
mediated repression. We recently demonstrated that CodY is
a repressor of PIA synthesis in the closely related species S.
aureus (45); thus, it seems unlikely that CodY is an activator of
icaADBC transcription in S. epidermidis. Investigations are un-
der way to determine the function of CodY in regulating S.
epidermidis PIA synthesis.
In gram-positive bacteria, carbon catabolite repression is
primarily mediated by CcpA (28). Recently, CcpA was shown
to activate transcription of icaADBC and increase the accumu-
lation of PIA in S. aureus (60). In B. subtilis, CcpA regulatory
activity is controlled by interactions with phosphorylated HPr
or Crh and fructose-1,6,-bisphosphate or glucose-6-phosphate
(67). NMR analysis indicated that TCA cycle inactivation in-
creased the intracellular concentration of fructose-6-phos-
phate (Table 3). Fructose-6-phosphate is the biosynthetic
precursor of UDP-N-acetylglucosamine. In addition to its im-
portance in PIA biosynthesis, fructose-6-phosphate can be re-
versibly isomerized to glucose-6-phosphate by glucose-6-phos-
phate isomerase, resulting in CcpA activation. Taken together,
these data lead us to hypothesize that TCA cycle inactivation
increases CcpA-mediated activation of icaADBC.
Conclusion. TCA cycle activity is repressed during the
exponential growth phase; however, a basal level of activity is
present. As evidenced by the data in this study, disruption of
this basal activity can have pronounced metabolic conse-
quences. TCA cycle activity is regulated by the availability of
nutrients, oxygen, and iron (8, 62, 65, 71, 76) and by certain
stress-inducing stimuli, such as heat, ethanol, and antibiotics
(6, 36, 73); thus, numerous external conditions can interfere
with the basal TCA cycle activity and produce metabolic
changes. The linkage of TCA cycle activity and exopolysaccha-
ride synthesis and the susceptibility of the TCA cycle to envi-
ronmental inactivation lead us to speculate that one mecha-
nism by which staphylococci perceive external environmental
change is through alterations in TCA cycle activity. Thus, we
hypothesize that the TCA cycle acts as a novel signal transduc-
tion pathway to translate external stimuli/conditions into intra-
cellular signals that can stimulate or repress the activity of
regulatory proteins like CodY and CcpA.
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 Supplemental Figure 1. NMR overlay spectra of S. epidermidis strain 1457 and strain 1457-
acnA grown for 2 hours. The spectrum for strain 1457 is displayed in red and the spectrum for 
strain 1475-acnA is displayed in blue. Peaks of metabolites of interest are indicated within the 
figure. The data are representative of spectra collected from three independent cultures. 
 
  
Supplemental Figure 2. NMR overlay spectra of S. epidermidis strain 1457 and strain 1457-
acnA grown for 6 hours. The spectrum for strain 1457 is displayed in red and the spectrum for 
strain 1475-acnA is displayed in blue. Peaks of metabolites of interest are indicated within the 
figure. The data are representative of spectra collected from three independent cultures. 
 
